HIT — Health In Tech, Inc.
NASDAQ
Q4 2025 Earnings Call Summary
March 25, 2026
Health In Tech, Inc. (HIT) Q4 2025 Earnings Call Summary
1. Key Financial Results and Metrics
- Full Year 2025 Revenue: Increased by 71% to $333.3 million.
- Q4 2025 Revenue: Rose by 53% to $7.5 million.
- Adjusted EBITDA: Full year adjusted EBITDA was $4.1 million (12.3% of revenue), up 81% year-over-year. Q4 adjusted EBITDA was $300,000, down from $500,000 in the prior year.
- Net Income: Full year net income reached $1.2 million (4% of revenue), up 91% year-over-year. Q4 net income was a loss of $300,000, compared to a loss of $100,000 in the prior year.
- Operating Expenses: Total operating expenses for the year were $19.4 million (58% of revenue), improving by 16% year-over-year.
- Cash Flow: Generated $3.1 million in positive operating cash flow; ended the year with $7.7 million in cash and cash equivalents.
2. Strategic Updates and Business Highlights
- Distribution Expansion: Increased network to 858 brokers, TPAs, and agency partners, a 34% year-over-year rise.
- Platform Development: Launched Enhanced Do-It-Yourself Benefit Systems (EDIBS) for larger employers, reducing underwriting timelines significantly.
- Program Development: Advanced a three-year rate stabilization program aimed at providing pricing predictability for employers.
- AI Integration: Continued investment in AI capabilities to enhance underwriting processes and improve operational efficiency.
3. Forward Guidance and Outlook
- 2026 Revenue Guidance: Projected revenue of $45 million to $50 million, indicating 35% to 50% year-over-year growth.
- Strategic Priorities for 2026: Focus on scaling distribution, enhancing platform capabilities, and expanding into claims administration and cost-containment solutions.
4. Bad News, Challenges, or Points of Concern
- Q4 Performance: Despite strong annual growth, Q4 net income showed a loss, reflecting planned reinvestments in growth initiatives.
- Long Sales Cycles: The transition to larger employer offerings may face extended sales cycles, potentially delaying revenue recognition.
- Market Penetration: Although growth is strong, the company acknowledges that it remains at a very early stage of market penetration in a large, competitive landscape.
5. Notable Q&A Insights
- Large Employer Offering: Initial feedback is positive, but significant revenue contributions from this segment are expected to materialize in 2026 due to long sales cycles.
- Three-Year Rate Stabilization Program: Interest is high among municipalities, with a beta test underway; official launch anticipated in the second half of 2026.
- AI Initiatives: Plans to leverage AI for improving claims processing and underwriting efficiency, with a focus on reducing manual intervention.
- Partnerships: Ongoing discussions about expanding partnerships to enhance service offerings and distribution capabilities.
Overall, HIT demonstrated robust growth in 2025, with a clear strategy for future expansion despite some challenges related to market penetration and the timing of sales cycles.
